RT Journal Article
SR Electronic
T1 ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP thoraxjnl-2020-215818
DO 10.1136/thoraxjnl-2020-215818
A1 Swapna Mandal
A1 Joseph Barnett
A1 Simon E Brill
A1 Jeremy S Brown
A1 Emma K Denneny
A1 Samanjit S Hare
A1 Melissa Heightman
A1 Toby E Hillman
A1 Joseph Jacob
A1 Hannah C Jarvis
A1 Marc C I Lipman
A1 Sindhu B Naidu
A1 Arjun Nair
A1 Joanna C Porter
A1 Gillian S Tomlinson
A1 John R Hurst
A1 ,
YR 2020
UL http://thorax.bmj.com/content/early/2020/11/09/thoraxjnl-2020-215818.abstract
AB Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.